NASDAQ:XENT
Intersect ENT, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Medical - Deviceswebsite
www.intersectent.comipo date
Jul 24, 2014
Intersect ENT, Inc. operates as an ear, nose, and throat (ENT) medical technology company in the United States. The company offers PROPEL, a steroid releasing implant to open the surgically enlarged sinus; PROPEL Mini, a releasing implant to treat patients undergoing frontal sinus surgery; and PROPEL Contour, a steroid releasing implant for the treatment of frontal and maxillar...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus